47
Participants
Start Date
January 31, 2006
Primary Completion Date
January 31, 2012
Study Completion Date
January 31, 2012
gemcitabine, docetaxel, doxorubicin
Cycles = 28 days
Memorial Sloan Kettering Cancer Center, New York
Pennsylvania Oncology Hematology Associates, Philadelphia
Washington Cancer Institute/Washington Hospital Center (Medstar), Washington D.C.
Winship Cancer Institute at Emory University, Atlanta
H. Lee Moffitt Cancer Center and Research Institute, Tampa
St. Vincent Gynecologic Oncology, Indianapolis
University of Michigan, Ann Arbor
University of Chicago, Chicago
Nebraska Methodist Hospital, Omaha
MD Anderson Cancer Center, Houston
Dana Farber Cancer Institute, Boston
Massachusetts General, Boston
Sarcoma Alliance for Research through Collaboration
OTHER